ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DOW Dow Chemical Company (The) (delisted)

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Dow Chemical Company (The) (delisted) AMEX:DOW AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

EARNINGS PREVIEW: US Chemical Cos Weighed Down By Demand Woes

13/10/2009 8:49pm

Dow Jones News


Dow Chemical Company (The) (delisted) (AMEX:DOW)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Dow Chemical Company (The) (delisted) Charts.

TAKING THE PULSE: Despite signs that business is picking up, or at least stabilizing, major U.S. chemical makers' results for the latest quarter are likely to reflect a continuing scramble to cope with demand woes. Standard & Poor's said in late September that quarter-to-quarter volume was improving, and that results are being helped by companies' cost and spending cuts, as well as lower raw-material prices. Nevertheless, most of the bellwether industry's biggest players are expected to report double-digit percentage profit and revenue declines.

 
   COMPANIES TO WATCH: 
 
   DuPont Co. (DD) - reports Oct. 20 
 

Wall Street's Expectations: Analysts surveyed by Thomson Reuters project third-quarter earnings of 33 cents a share on revenue of $6.16 billion, down from 40 cents and $7.3 billion, respectively, a year earlier.

Key Issues: DuPont in July credited government stimulus spending and customers' restocking for a slight uptick in business. Cost-cutting and agribusiness revenue growth also helped it beat second-quarter expectations, but Chief Executive Ellen Kullman said she expected third-quarter volume to remain below year-ago levels. The company has continued to branch out from its traditional chemicals business, recently investing more than $120 million to boost solar-panel capacity.

 
   Dow Chemical Co. (DOW) - reports Oct. 22 
 

Wall Street's Expectations: The company is expected to post earnings of 9 cents a share on revenue of $11.87 billion, down from 46 cents and $15.41 billion, respectively, a year ago.

Key Issues: Dow Chemical in July forecast an upswing in third-quarter business conditions, but Chairman and CEO Andrew Liveris ruled out a significant turnaround for the rest of the year. The company is in the midst of reorganizing its business to absorb its $16.3 billion acquisition of Rohm & Haas and manage the heavy debt load it incurred in the purchase. Dow has been selling assets, most recently the $1.68 billion sale of its Morton Salt business.

 
   Eastman Chemical Co. (EMN) - reports Oct. 22 
 

Wall Street Expectations: Analysts forecast earnings of $1.13 on revenue of $1.33 billion. The prior-year figures were $1.33 a share and $1.82 billion.

Key Issues: The maker of specialty chemicals, synthetic fibers and plastics issued a surprisingly upbeat third-quarter forecast in July as demand improved slightly after customers' inventory cuts. But CEO Jim Rogers cautioned that he expected second-half demand to remain near then-current levels, with raw material and energy costs rising slightly. Sales in the company's largest unit, performance chemicals, fell 51% in the second quarter.

 
   Ashland Inc. (ASH) - reporting date to be announced 
 

Wall Street's Expectations: Analysts estimate fiscal fourth-quarter earnings of 90 cents a share on revenue of $2.07 billion. A year ago, the company reported a 15-cent loss on revenue of $2.22 billion.

Key Issues: Chairman and CEO James O'Brien said in July demand could remain flat for the "foreseeable future." Ashland saw volume declines in all businesses except its Valvoline motor-oil unit during the prior quarter. Like Dow Chemical, Ashland is trying to pay down debt from an acquisition - in this case, its $2.6 billion purchase last year of Hercules.

(The Thomson Reuters estimate and year-earlier earnings may not be comparable due to one-time items and other adjustments.)

-By Mike Barris, Dow Jones Newswires; 212-416-2330; mike.barris@dowjones.com

 
 

1 Year Dow Chemical Company (The) (delisted) Chart

1 Year Dow Chemical Company (The) (delisted) Chart

1 Month Dow Chemical Company (The) (delisted) Chart

1 Month Dow Chemical Company (The) (delisted) Chart

Your Recent History

Delayed Upgrade Clock